Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet Breastfeeding

American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet for its safety in breastfeeding.

What is Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet used for?


BENICAR HCT ® is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy (see DOSAGE AND ADMINISTRATION ).

Can I continue breastfeeding if I am using Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet? How long does it stays in breast milk?

Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet low risk for breastfeeding
Olmesartan medoxomil and Hydrochlorothiazide are the two main ingredients of Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet. Based on our individual analysis of Olmesartan medoxomil and Hydrochlorothiazide we can safely say that Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet has low risk while breastfeeding. Below we have summarized the usage of Olmesartan medoxomil and Hydrochlorothiazide while breastfeeding, we recommend you to go through it for better understanding of your usage.

Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet Breastfeeding Analsys


Olmesartan medoxomil while Breastfeeding

Low Risk

CAS Number: 144689-63-4

At latest update, relevant published data on excretion into breast milk were not found. A high protein-binding capacity makes excretion into breast milk unlikely. In addition, a low oral bioavailability makes difficult the absorption towards the infant's plasma from ingested milk, except in prematures or newborns who may show an increased absorption. Case report of kidney function impairment of a baby whose mother had taken Telmisartan in pregnancy. Until more data on this medication is available, safer alternative drugs are preferred, especially in premature babies or during the neonatal period. Should an ARA-II medication (Sartan type) be necessary, the associated risk may be decreased by choosing the one with a favorable pharmacokinetics (shorter half-life elimination time and lower bioavailability) like Eprosartan and Losartan

Hydrochlorothiazide while Breastfeeding

Safe

CAS Number: 58-93-5

Is Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet safe while breastfeeding

Thiazide diuretic drug. Excretion into breast milk is clinically non-significant. No side-effects were observed in a one-month old breastfed baby whose mother was treated with this medication. Drug level in the plasma of this child was undetectable. Long-term treatment with diuretic drugs (particularly Thiazide type ones with long-lasting effect and loop-acting mechanism) may inhibit lactation, mostly if lactation is not well-established yet. Use as lower dose as possible, especially during the first postnatal month. American Academy of Pediatrics 2013: Maternal Medication Usually Compatible With Breastfeeding. WHO Model List of Essential Drugs 2002: Compatible with breastfeeding.


Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet Breastfeeding Analsys - 2


Olmesartan medoxomil while Breastfeeding

CAS Number: 144689-24-7

Because no information is available on the use of olmesartan during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Hydrochlorothiazide while Breastfeeding

CAS Number: 58-93-5

Hydrochlorothiazide doses of 50 mg daily or less are acceptable during lactation. Intense diuresis with large doses may decrease breastmilk production.


Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet safe for breastfeeding

I already used Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet and meanwhile I breastfed my baby should I be concerned?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet then you shall inform your doctor, But you should not be worried too much as Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet comes in category of low risk drug.


My doctor has prescribed me Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet, what should I do?

Though Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Benicar Hct | Olmesartan Medoxomil And Hydrochlorothiazide Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients